# Sunflower Therapeutics, PBC — Form D

Sunflower Therapeutics, PBC of Hingham, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-24. The offering totals $3.0M, of which $2.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-05-24
- Form: D
- Accession: 0001950773-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.0M
- Remaining: $970K
- Investors: 2
- Date of first sale: 2024-05-13
- Revenue range: Decline to Disclose
- SEC file number: 021-514263

## Issuer

- Name: Sunflower Therapeutics, PBC
- CIK: 0001950773
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 18 Shipyard Dr., Ste. 2A, Hingham, MA, 02043
- Phone: 781-539-8100

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Maik R Jornitz | Director | Hingham, MA |
| J. Christopher R Love | Director | Hingham, MA |
| Kerry R Love | Director | Hingham, MA |
| Larry R Weiner | Director | Hingham, MA |
| Kerry R Love | Executive Officer | Hingham, MA |
| Kathryn R Golden | Director | Hingham, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-10-14](https://search.stillhousedata.com/formd/0001950773-22-000001) | D | $1.5M | $610K |

## More

- [CIK 1950773 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1950773&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001950773-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.